This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Institute for Johns Hopkins Nursing is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
eNewsletter: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Podcast: The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
eNewsletter: This 1 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each Newsletter carries a maximum of 1 contact hours or a total of 6 contact hours for the six newsletters in this program.
Podcast: This 0.5 contact hour Educational Activity is provided by the Institute for Johns Hopkins Nursing. Each podcast carries a maximum of 0.5 contact hours or a total of 1.5 contact hours for the three podcasts in this program.
To take the post-test for eMedicalDermatology Review you will need to visit the Johns Hopkins University School of Medicine's CME website and the Institute for Johns Hopkins Nursing. If you have already registered for another Hopkins CME program at these sites, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. A passing grade of 70% or higher on the post-test/evaluation is required to receive CME/CNE credit.
The Johns Hopkins University School of Medicine and the Institute for Johns Hopkins Nursing take responsibility for the content, quality and scientific integrity of this CME/CNE activity.
This activity has been developed for Dermatologists, Nurses, Dermasurgeons, Dermatopathologists, Pediatric Dermatologists, Immunodermatologists, Wound Care Specialists and Allied Healthcare providers.
At the conclusion of this activity, participants should be able to:
- Identify current key topics related to the diagnosis and treatment of medical dermatological conditions
- Discuss how the information presented may impact current clinical paradigms
- Evaluate how the information presented may best be incorporated into current clinical practice
This program launched on September 15, 2009 and is published bi-monthly; activities expire 2 years from the date of publication, ending in May 2012.
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine (SOM) and the Institute for Johns Hopkins Nursing are committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine’s CME program. CME collects only the information necessary to provide you with services that you request.
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any relevant financial interest or any other relationship a faculty member or a provider has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Bernard A. Cohen, MD, has indicated he has received grants for studies from Novartis Pharmaceuticals and Astellas Pharma Inc.
Susan Matra Rabizadeh, MD, MBA, has disclosed no relationships with commercial supporters.
Mark Lebwohl, MD, has disclosed that he has received grants for clinical research and educational activities from, has served as an advisor or consultant to Abbott, Actelion Clinical Research, Amgen/Wyeth, Astellas, Centocor, Cerexa, DermiPsor, Electro Optical Sciences, Galderma, Genentech, GlaxoSmithKline, Graceway, Helix BioMedix, Magen Biosciences, Medicis, NeoStrata, Novartis, Nycomed, Peplin, Pfizer, PharmaDerm, Ranbaxy, Sanofi-Aventis, Stiefel, Taro, Triax and Warner Chilcott. Dr. Lebwohl has also disclosed that he serves as a speaker for Abbott, Amgen/Wyeth, Astellas, Centocor, Galderma, Genentech, GlaxoSmithKline, Novartis, Triax and Warner Chilcott.
Elizabeth Sloand, PhD, CRNP, has disclosed no relationships with commercial supporters.
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Copyright © 2010 JHUSOM, IJHN and eMedicalDermatology Review
Presented by JHUSOM and IJHN in collaboratioin with DKBmed. |
